Yohei Maeda

Dr. Yohei Maeda

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2020 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
TYTakashi Yoshioka
Takashi Yoshioka
YMYohei Maeda
Yohei Maeda
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

16 September 2022 in Allergology International
Verified
Journal Article
Open access
ANAyaka Nakatani
Ayaka Nakatani
TTTakeshi Tsuda
Takeshi Tsuda
YMYohei Maeda
Yohei Maeda
MHMasaki Hayama
Masaki Hayama
DODaisuke Okuzaki
Daisuke Okuzaki
HIHidenori Inohara
Hidenori Inohara
Chronic rhinosinusitis is classified into eosinophilic chronic rhinosinusitis (ECRS) and non-eosinophilic chronic rhinosinusitis (NECRS). ECRS is a refractory allergic disease involving a variety of immune and epithelial cells. S100A8 is a damage-associated molecular pattern that is closely related to allergic inflammation. However, the pathological implications of S100A8 in ECRS have not been clarified. We evaluated the role of S100A8 in the pathogenesis of ECRS. Gene expression profiles of nasal polyps obtained from patients with ECRS or NECRS were evaluated using RNA sequencing. S100A8 was identified as a significantly upregulated gene in nasal polyps associated with ECRS. Immunohistochemistry consistently revealed intense S100A8 staining in nasal polyps from patients with ECRS. Human nasal epithelial cells expressed the receptor for advanced glycation end products and Toll-like receptor 4. Recombinant S100A8 protein induced interleukin-1β secretion in human nasal epithelial cells. Our data demonstrate that S100A8 results in production of interleukin-1β in the nasal epithelium, which may be involved in the pathogenesis of ECRS.

27 June 2022 in Allergy
Verified
Journal Article
Closed access
SHSoichiro Haruna
Soichiro Haruna
KTKazuya Takeda
Kazuya Takeda
MEMarwa Ali El‐Hussien
Marwa Ali El‐Hussien
YMYohei Maeda
Yohei Maeda
MHMasaki Hayama
Masaki Hayama
SSShuhei Sakakibara
Shuhei Sakakibara

25 November 2023 in Auris Nasus Larynx
Verified
Journal Article
Closed access
MHMasaki Hayama
Masaki Hayama
YMYohei Maeda
Yohei Maeda
SOSho Obata
Sho Obata
TTTakeshi Tsuda
Takeshi Tsuda
KTKazuya Takeda
Kazuya Takeda
HIHidenori Inohara
Hidenori Inohara

27 January 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
KTKosuke Takabayashi
Kosuke Takabayashi
YMYohei Maeda
Yohei Maeda
NKNobuya Kataoka
Nobuya Kataoka
HKHiroyuki Kagokawad
Hiroyuki Kagokawad
MNMasayoshi Nagaminea
Masayoshi Nagaminea
TFTaketoshi Fujita
Taketoshi Fujita
Pediatric orbital blowout fractures can include pathologies that seem mild but require urgent release; serious sequelae can occur with standby surgery or conservative treatment. We sought to validate an algorithm for the treatment of pediatric orbital blowout fractures. This retrospective cohort study included 61 pediatric patients, aged 18 years or younger, treated for pure orbital blowout fractures according to the algorithm from April 1, 2000, to August 31, 2020, at the Japanese Red Cross Asahikawa Hospital. There were 52 males (85%). Median age was 14 years (range, 5–18 years). There were 9 patients categorized as needing urgent release, 16 as needing repair, and 36 as needing conservative treatment. Mean follow-up ocular movement was 98.0 (95% Confidence Interval [95% CI], 96.8–99.2). Postoperative diplopia was not observed in 96% (79.6%–99.9%) of patients, better than in previous studies. A higher proportion of patients aged 0–12 years needed urgent repair than those aged 13–18 years (Odds Ratio [OR] = 14.2; 95% CI 1.6–683.4; p = 0.0046). There were no differences in Hess area ratio by age group. Clinical results with the algorithm were satisfactory. The algorithm is suitable for treatment of pediatric orbital blowout fractures. 4.

7 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NANaoki Ashida
Naoki Ashida
YMYohei Maeda
Yohei Maeda
TKTakahiro Kitamura
Takahiro Kitamura
MHMasaki Hayama
Masaki Hayama
TTTakeshi Tsuda
Takeshi Tsuda
HIHidenori Inohara
Hidenori Inohara
Isolated sphenoid sinus opacifications (ISSOs) are clinically important because they can lead to serious complications. However, some patients with ISSOs are asymptomatic, and not all patients are properly referred to the otolaryngology department. Because past studies of ISSOs focused only on patients who received treatment, in this study we selected ISSO cases based on radiology reports, then determined whether these patients had symptoms and were appropriately referred for specialty care. We conducted a retrospective analysis of data collected from patients who underwent computed tomography or magnetic resonance imaging from January 2007 to March 2017 at Osaka General Medical Center. We searched for the terms “sphenoid” or “sphenoidal” using F-REPORT to identify patients who had a sphenoid disease. We checked all selected images and diagnosed ISSOs. Examination of 1115 cases revealed 223 cases of ISSOs, of whom 167 (74.9%) were asymptomatic. We categorized patients with ISSOs into four groups: inflammation, mucocele, fungal diseases, and unclassifiable; the final category was used when edges were irregular or complete opacity was encountered. In the unclassifiable group, the majority of cases required otolaryngology consultation, but 37 of 47 unclassifiable patients did not have an otolaryngology visit. ISSOs are often identified by chance on imaging tests performed by non-otolaryngologists. However, our study revealed that many patients with ISSOs who should be treated by otolaryngologists were not referred to the otolaryngology department. Accordingly, it is important to promote awareness of the disease among other types of clinicians.